Degeneration of adrenergic nerves produced by 6-hydroxydopamine

European Journal of Pharmacology - Tập 3 - Trang 89-92 - 1968
Torbjörn Malmfors1, Charlotte Sachs1
1Department of Histology, Karolinska Institutet, Stockholm 60, Sweden

Tài liệu tham khảo

Corrodi, 1967, The formaldehyde fluorescence method for the histochemical demonstration of biogenic monoamines. A review on the methodology, J. Histochem. Cytochem., 15, 65, 10.1177/15.2.65 Dahlström, 1966, The intraneuronal distribution of noradrenaline and the transport and life-span of amine storage granules in the sympathetic adrenergic neuron, M.D. Thesis Falck, 1965, A detailed methodological description of the fluorescence method for the cellular demonstration of biogenic monoamines, Acta Univ. Lund. Laverty, 1965, Action of 2, 4, 5-trihydroxyphenylethylamine on the storage and release of noradrenaline, Brit. J. Pharmacol., 24, 549 Malmfors, 1965, Studies on adrenergic nerves. The use of rat and mouse iris for direct observation on their physiology and pharmacology at cellular and subcellular levels, Acta Physiol. Scand., 64 Malmfors, 1967, Adrenergic reinnervation of anterior chamber transplants, Acta Physiol. Scand., 71, 401, 10.1111/j.1748-1716.1967.tb03747.x Malmfors, 1965, Direct studies on the disapperance of the transmitter and changes in the uptake-storage mechanisms of degenerating nerves, Acta Physiol. Scand., 64, 211, 10.1111/j.1748-1716.1965.tb04171.x Porter, 1963, Effect of 6-hydroxydopamine and some other components on the concentration of norepinephrine in the hearts of mice, J. Pharmacol. Exp. Ther., 140, 308 Porter, 1965, The relationship between radioactivity and norepinephrine concentrations in the brains and hearts of mice following administration of labeled methyldopa or 6-hydroxydopamine, J. Pharmacol. Exp. Ther., 150, 17 Thoenen, 1968, Mechanisms of amphetamine accumulation in the isolated perfused heart of the rat, J. Pharm. Pharmacol., 20, 1, 10.1111/j.2042-7158.1968.tb09611.x Tranzer von, 1967, Ultramorphologische Veränderungen der sympathischen Nervendigungen der Katze nach Vorbehandlung mit 5- und 6-Hydroxy-Dopamin, Arch. Pharmacol. Exp. Path., 257, 342